16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Microenvironment cues involved in melanoma progression are largely unknown. Melanoma is highly influenced in its aggressive phenotype by the changes it determinates in its microenvironment, such as pH decrease, in turn influencing cancer cell invasiveness, progression and tissue remodelling through an abundant secretion of exosomes, dictating cancer strategy to the whole host. A role of exosomes in driving melanoma progression under microenvironmental acidity was never described.

          Methods

          We studied four differently staged human melanoma lines, reflecting melanoma progression, under microenvironmental acidic pHs pressure ranging between pH 6.0–6.7. To estimate exosome secretion as a function of tumor stage and environmental pH, we applied a technique to generate native fluorescent exosomes characterized by vesicles integrity, size, density, markers expression, and quantifiable by direct FACS analysis.

          Functional roles of exosomes were tested in migration and invasion tests. Then we performed a comparative proteomic analysis of acid versus control exosomes to elucidate a specific signature involved in melanoma progression.

          Results

          We found that metastatic melanoma secretes a higher exosome amount than primary melanoma, and that acidic pH increases exosome secretion when melanoma is in an intermediate stage, i.e. metastatic non-invasive.

          We were thus able to show that acidic pH influences the intercellular cross-talk mediated by exosomes. In fact when exposed to exosomes produced in an acidic medium, pH naïve melanoma cells acquire migratory and invasive capacities likely due to transfer of metastatic exosomal proteins, favoring cell motility and angiogenesis.

          A Prognoscan-based meta-analysis study of proteins enriched in acidic exosomes, identified 11 genes (HRAS, GANAB, CFL2, HSP90B1, HSP90AB1, GSN, HSPA1L, NRAS, HSPA5, TIMP3, HYOU1), significantly correlating with poor prognosis, whose high expression was in part confirmed in bioptic samples of lymph node metastases.

          Conclusions

          A crucial step of melanoma progression does occur at melanoma intermediate –stage, when extracellular acidic pH induces an abundant release and intra-tumoral uptake of exosomes. Such exosomes are endowed with pro-invasive molecules of clinical relevance, which may provide a signature of melanoma advancement.

          Electronic supplementary material

          The online version of this article (10.1186/s13046-018-0915-z) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: found

          On the origin of cancer cells.

          O WARBURG (1956)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            PrognoScan: a new database for meta-analysis of the prognostic value of genes

            Background In cancer research, the association between a gene and clinical outcome suggests the underlying etiology of the disease and consequently can motivate further studies. The recent availability of published cancer microarray datasets with clinical annotation provides the opportunity for linking gene expression to prognosis. However, the data are not easy to access and analyze without an effective analysis platform. Description To take advantage of public resources in full, a database named "PrognoScan" has been developed. This is 1) a large collection of publicly available cancer microarray datasets with clinical annotation, as well as 2) a tool for assessing the biological relationship between gene expression and prognosis. PrognoScan employs the minimum P-value approach for grouping patients for survival analysis that finds the optimal cutpoint in continuous gene expression measurement without prior biological knowledge or assumption and, as a result, enables systematic meta-analysis of multiple datasets. Conclusion PrognoScan provides a powerful platform for evaluating potential tumor markers and therapeutic targets and would accelerate cancer research. The database is publicly accessible at .
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis.

              Exosomes are naturally occurring biological nanovesicles utilized by tumors to communicate signals to local and remote cells and tissues. Melanoma exosomes can incite a proangiogenic signaling program capable of remodeling tissue matrices. In this study, we show exosome-mediated conditioning of lymph nodes and define microanatomic responses that license metastasis of melanoma cells. Homing of melanoma exosomes to sentinel lymph nodes imposes synchronized molecular signals that effect melanoma cell recruitment, extracellular matrix deposition, and vascular proliferation in the lymph nodes. Our findings highlight the pathophysiologic role and mechanisms of an exosome-mediated process of microanatomic niche preparation that facilitates lymphatic metastasis by cancer cells.
                Bookmark

                Author and article information

                Contributors
                zaira.boussadia@iss.it
                jessica_lamberti@libero.it
                fabrizio.mattei@iss.it
                elisabetta.pizzi@iss.it
                rossella.puglisi@iss.it
                cristiana.zanetti@iss.it
                luca.pasquini@iss.it
                federica.fratini@iss.it
                luca.fantozzi@iss.it
                federica.felicetti@iss.it
                katia.fecchi@iss.it
                carla.raggi@iss.it
                massimo.sanchez@iss.it
                s.datri@idi.it
                alessandra.care@iss.it
                massimo.sargiacomo@iss.it
                +39 06 4990 2987 , isabella.parolini@iss.it
                Journal
                J Exp Clin Cancer Res
                J. Exp. Clin. Cancer Res
                Journal of Experimental & Clinical Cancer Research : CR
                BioMed Central (London )
                0392-9078
                1756-9966
                5 October 2018
                5 October 2018
                2018
                : 37
                : 245
                Affiliations
                [1 ]ISNI 0000 0000 9120 6856, GRID grid.416651.1, Global Health Center, Istituto Superiore di Sanità, ; Rome, Italy
                [2 ]ISNI 0000 0000 9120 6856, GRID grid.416651.1, Oncology and Molecular Medicine Department, Istituto Superiore di Sanità, ; Rome, Italy
                [3 ]ISNI 0000 0000 9120 6856, GRID grid.416651.1, Major Equipments and Core Facilities, Istituto Superiore di Sanità, ; Rome, Italy
                [4 ]ISNI 0000 0000 9120 6856, GRID grid.416651.1, National Center for the Control and Evaluation of Medicine, Istituto Superiore di Sanità, ; Rome, Italy
                [5 ]ISNI 0000 0000 9120 6856, GRID grid.416651.1, Center for Gender- specific Medicine, Istituto Superiore di Sanità, Istituto Superiore di Sanità, ; Rome, Italy
                [6 ]ISNI 0000 0004 1758 0179, GRID grid.419457.a, Laboratory of Molecular Oncology, Istituto Dermopatico dell’Immacolata- IRCCS, ; Rome, Italy
                Author information
                http://orcid.org/0000-0001-9863-1051
                Article
                915
                10.1186/s13046-018-0915-z
                6173926
                30290833
                b482a503-ec4c-45e4-b086-0232d9a9e897
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 29 January 2018
                : 24 September 2018
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100003196, Ministero della Salute;
                Award ID: RF-2011-02347300
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2018

                Oncology & Radiotherapy
                exosomes,melanoma progression,tumor stage,microenvironmental acidic ph
                Oncology & Radiotherapy
                exosomes, melanoma progression, tumor stage, microenvironmental acidic ph

                Comments

                Comment on this article